674774-74-4

Basic information

• Product Name: 1-[4,4']BIPIPERIDINYL-1-YL-ETHANONE
• Synonyms: 1-ACETYL-4,4'-BIPIPERIDINE;1-[4,4']BIPIPERIDINYL-1-YL-ETHANONE
• CAS NO: 674774-74-4
• Molecular Formula: C12H22N2O
• Molecular Weight: 210.32
• Mol File: 674774-74-4.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 1-[4,4']BIPIPERIDINYL-1-YL-ETHANONE(CAS DataBase Reference)
• NIST Chemistry Reference: 1-[4,4']BIPIPERIDINYL-1-YL-ETHANONE(674774-74-4)
• EPA Substance Registry System: 1-[4,4']BIPIPERIDINYL-1-YL-ETHANONE(674774-74-4)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 674774-74-4(Hazardous Substances Data)

Usage

Chemical class

Piperidine derivative

Functional group

Ketone

Applications

a. Pharmaceutical research and development
b. Organic synthesis
c. Building block for other chemical compounds
d. Medicinal chemistry and drug discovery

Therapeutic potential

a. Neurological disorders
b. Substance abuse treatment

Pharmacological properties

Investigated for its potential therapeutic benefits and effects on various medical conditions.

Upstream product

• 15336-72-8 4,4'-bipiperidine 
• 108-24-7 acetic anhydride 

Relevant articles and documents

SMALL MOLECULE INHIBITORS OF HER2 EXPRESSION

Peptide mimetic small molecule inhibitors of Sur-2 are provided having the general formula (I).

A Wrench-Shaped Synthetic Molecule that Modulates a Transcription Factor-Coactivator Interaction

Development of synthetic molecules that provide external control over the transcription of a given gene represents a challenge in medicinal and bioorganic chemistry. Here we report design and analysis of wrenchnolol, a wrench-shaped synthetic molecule that impairs the transcription of the Her2 oncogene by disrupting association of transcription factor ESX with its coactivator Sur-2. The "jaw" part of the compound mimics the α-helical interface of the activation domain of ESX, and the "handle" region accepts chemical modifications for a range of analysis. A water-soluble handle permitted NMR study in aqueous solution; a biotinylated handle verified the selectivity of the interaction, and a fluorescent handle confirmed the cell permeability of the compound. The case study of wrenchnolol foreshadows the promise and the challenge of targeting protein-protein interactions in the nucleus and may lead to the development of unique synthetic modulators of gene transcription.